Generic placeholder image

Current Enzyme Inhibition

Editor-in-Chief

ISSN (Print): 1573-4080
ISSN (Online): 1875-6662

Proteolytic Enzymes and Their Inhibition in Epithelial Ovarian Cancer

Author(s): A. McDonnel Smedts, T. E. Curry Jr. and W. J. Murdoch

Volume 1, Issue 2, 2005

Page: [157 - 170] Pages: 14

DOI: 10.2174/1573408054022199

Price: $65

Abstract

Common (surface) epithelial cancer of the ovary is epitomized by metastasis to organs of the abdominal cavity. Proteolytic enzymes, predominately those of the matrix metalloproteinase and plasminogen activator-plasmin systems, have been implicated as mediators of tissue invasion. This review highlights the salient features of ovarian cancer progression, the proteases involved, and experimental approaches of inhibition. Enzyme inhibitors hold promise in the treatment of early-stage and recurrent (following cytoreductive surgery) disease.

Keywords: matrix metalloproteinase, urokinase, kallikrein, ovarian cancer, protease inhibitor


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy